Helixmith&#39;s Chinese Partner Enzensis&#39; Second CLI Phase 3 Clinical Trial Also Achieves Primary Endpoint [Google translation]

Engensis (donaperminogene seltoplasmid) - Beijing Northland, Reyon Pharma, Helixmith

https://www.hankyung.com/article/202408199864P

Aug 22, 2024